J.W. COLE ADVISORS, INC. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
J.W. COLE ADVISORS, INC. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$155,989
-66.3%
18,6590.0%0.01%
-66.7%
Q2 2023$463,490
+65.2%
18,6590.0%0.03%
+65.0%
Q1 2023$280,631
+58.1%
18,659
+24.4%
0.02%
+42.9%
Q4 2022$177,450
+99.4%
15,0000.0%0.01%
+100.0%
Q3 2022$89,000
+39.1%
15,0000.0%0.01%
+40.0%
Q2 2022$64,000
-55.2%
15,0000.0%0.01%
-50.0%
Q1 2022$143,000
-49.8%
15,0000.0%0.01%
-47.4%
Q4 2021$285,000
-42.9%
15,0000.0%0.02%
-47.2%
Q3 2021$499,00015,0000.04%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 5,229,619$74,261,0003.55%
RA Capital Management 2,472,344$35,107,0002.69%
SENZAR ASSET MANAGEMENT, LLC 475,918$6,758,0002.13%
BRIDGER MANAGEMENT, LLC 2,373,920$33,710,0002.04%
Opaleye Management Inc. 274,200$3,893,0001.11%
Virtus ETF Advisers LLC 89,920$1,277,0001.11%
Eversept Partners, LP 150,000$2,130,0000.99%
Ghost Tree Capital, LLC 300,000$4,260,0000.86%
PURA VIDA INVESTMENTS, LLC 50,000$710,0000.42%
HIGHLAND CAPITAL MANAGEMENT LP 464,391$6,595,0000.34%
View complete list of TG THERAPEUTICS INC shareholders